1
|
Faye AS, Axelrad JE. Editorial: safety in numbers-cycling of biologics does not increase risk of adverse outcomes. Aliment Pharmacol Ther 2022; 55:1459-1460. [PMID: 35538352 PMCID: PMC9102742 DOI: 10.1111/apt.16936] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/09/2022]
Affiliation(s)
- Adam S. Faye
- Inflammatory Bowel Disease Center at NYU Langone Health, Division of Gastroenterology, Department of Medicine, NYU Grossman School of Medicine, New York, New York, U.S.,Correspondence to: Adam S. Faye, M.D., M.S., New York University School of Medicine, Division of Gastroenterology & Hepatology, NYU IBD Center, 303 East 33 Street, NYC, NY 10016, Tel: (855) 698-4232, Fax: (212) 263-3096,
| | - Jordan E. Axelrad
- Inflammatory Bowel Disease Center at NYU Langone Health, Division of Gastroenterology, Department of Medicine, NYU Grossman School of Medicine, New York, New York, U.S
| |
Collapse
|